PROTAC RIPK1 Degrader-1
Product Specifications
Target
PROTACs, RIP kinase
Related Pathways
NF-κB, Apoptosis, PROTAC
Bioactivity
PROTACRIPK1Degrader-1 is a selective RIPK1 PROTAC degrader. This compound degrades RIPK1 in various cancer cell lines, such as A375 and B16F10 cells. It enhances the anticancer effects of radiotherapy in both syngeneic and humanized mouse models. PROTACRIPK1Degrader-1 is applicable for research in cancers like melanoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040370-100 1x 100 µL
CD117 (C117/370), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC883241-100 1x 100 µL
Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy) (DMD/3241), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
